AtriCure, Inc. (ATRC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
59/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseATRC / S&P -1.93% / 15.20% |
LoseATRC / S&P 13.94% / 15.00% |
LoseATRC / S&P -127.27% / 50.40% |
| 2026-Q11/3 |
LoseATRC / S&P -27.88% / -4.33% |
WinATRC / S&P 15.01% / 11.30% |
LoseATRC / S&P -87.65% / 27.70% |
| 2025-Q42/3 |
WinATRC / S&P 12.23% / 2.65% |
WinATRC / S&P 14.88% / 9.00% |
LoseATRC / S&P -74.74% / 13.40% |
| 2025-Q31/3 |
LoseATRC / S&P 7.57% / 8.12% |
WinATRC / S&P 15.80% / 4.61% |
LoseATRC / S&P -26.51% / 13.45% |
| 2025-Q21/3 |
LoseATRC / S&P 1.58% / 10.94% |
WinATRC / S&P 16.28% / 4.83% |
LoseATRC / S&P -10.47% / 10.63% |
| 2025-Q12/3 |
WinATRC / S&P 5.56% / -4.27% |
WinATRC / S&P 15.79% / 4.98% |
LoseATRC / S&P 1.25% / 10.57% |
| 2024-Q43/3 |
WinATRC / S&P 8.99% / 2.41% |
WinATRC / S&P 16.55% / 5.25% |
WinATRC / S&P 43.94% / 6.15% |
| 2024-Q33/3 |
WinATRC / S&P 23.14% / 5.89% |
WinATRC / S&P 17.56% / 5.89% |
WinATRC / S&P 53.70% / 6.11% |
| 2024-Q22/3 |
LoseATRC / S&P -25.15% / 4.28% |
WinATRC / S&P 17.57% / 5.38% |
WinATRC / S&P 40.98% / 5.12% |
| 2024-Q11/3 |
LoseATRC / S&P -14.77% / 10.56% |
WinATRC / S&P 18.70% / 5.71% |
LoseATRC / S&P -2.44% / 5.59% |
| 2023-Q41/3 |
LoseATRC / S&P -18.52% / 11.69% |
WinATRC / S&P 20.84% / 6.81% |
LoseATRC / S&P -34.65% / 7.78% |
| 2023-Q31/3 |
LoseATRC / S&P -11.26% / -3.27% |
WinATRC / S&P 20.65% / 7.52% |
LoseATRC / S&P -55.74% / -5.03% |
| 2023-Q22/3 |
WinATRC / S&P 19.08% / 8.74% |
WinATRC / S&P 20.77% / 9.50% |
LoseATRC / S&P -152.59% / -8.57% |
| 2023-Q11/3 |
LoseATRC / S&P -6.60% / 7.50% |
WinATRC / S&P 20.60% / 10.77% |
LoseATRC / S&P -173.21% / -15.69% |
| 2022-Q42/3 |
WinATRC / S&P 13.50% / 7.56% |
WinATRC / S&P 20.43% / 11.88% |
LoseATRC / S&P -194.39% / -17.99% |
| 2022-Q32/3 |
WinATRC / S&P -4.31% / -4.88% |
WinATRC / S&P 21.92% / 13.47% |
LoseATRC / S&P -229.79% / -1.41% |
| 2022-Q21/3 |
LoseATRC / S&P -37.78% / -16.10% |
WinATRC / S&P 24.53% / 13.71% |
LoseATRC / S&P -190.63% / 11.04% |
| 2022-Q11/3 |
LoseATRC / S&P -5.55% / -4.60% |
WinATRC / S&P 36.24% / 15.97% |
LoseATRC / S&P ATRC unavailable / 42.23% |
| 2021-Q41/3 |
LoseATRC / S&P -0.03% / 11.03% |
WinATRC / S&P 32.83% / 15.00% |
LoseATRC / S&P ATRC unavailable / 96.40% |
| 2021-Q31/3 |
LoseATRC / S&P -12.33% / 0.58% |
WinATRC / S&P 23.18% / 10.77% |
LoseATRC / S&P ATRC unavailable / 69.42% |
| 2021-Q22/3 |
WinATRC / S&P 21.08% / 8.55% |
WinATRC / S&P 14.69% / 6.58% |
LoseATRC / S&P ATRC unavailable / 51.81% |
| 2021-Q11/3 |
WinATRC / S&P 17.69% / 6.17% |
LoseATRC / S&P -7.60% / -1.06% |
LoseATRC / S&P ATRC unavailable / 7.39% |
| 2020-Q41/3 |
WinATRC / S&P 39.52% / 12.15% |
LoseATRC / S&P -10.52% / -3.72% |
LoseATRC / S&P ATRC unavailable / -33.42% |
| 2020-Q30/3 |
LoseATRC / S&P -11.23% / 8.93% |
LoseATRC / S&P -5.51% / -2.04% |
LoseATRC / S&P ATRC unavailable / -27.10% |
| 2020-Q21/3 |
WinATRC / S&P 33.82% / 20.54% |
LoseATRC / S&P -1.73% / -0.46% |
LoseATRC / S&P ATRC unavailable / -27.11% |
| 2020-Q12/3 |
WinATRC / S&P 3.32% / -19.60% |
WinATRC / S&P 10.29% / 3.47% |
LoseATRC / S&P ATRC unavailable / -14.75% |
| 2019-Q42/3 |
WinATRC / S&P 30.35% / 9.07% |
WinATRC / S&P 14.47% / 5.36% |
LoseATRC / S&P ATRC unavailable / 2.99% |
| 2019-Q31/3 |
LoseATRC / S&P -16.42% / 1.70% |
WinATRC / S&P 14.16% / 5.02% |
LoseATRC / S&P ATRC unavailable / 0.21% |
| 2019-Q22/3 |
WinATRC / S&P 11.38% / 4.30% |
WinATRC / S&P 15.35% / 6.64% |
LoseATRC / S&P ATRC unavailable / 8.65% |
| 2019-Q11/3 |
LoseATRC / S&P -12.45% / 13.65% |
WinATRC / S&P 15.61% / 8.12% |
LoseATRC / S&P ATRC unavailable / 14.29% |
| 2018-Q42/3 |
WinATRC / S&P -12.65% / -13.52% |
WinATRC / S&P 15.40% / 9.05% |
LoseATRC / S&P ATRC unavailable / 18.23% |
| 2018-Q32/3 |
WinATRC / S&P 29.50% / 7.71% |
WinATRC / S&P 14.72% / 10.21% |
LoseATRC / S&P ATRC unavailable / 19.06% |
| 2018-Q22/3 |
WinATRC / S&P 31.82% / 3.43% |
WinATRC / S&P 12.65% / 9.03% |
LoseATRC / S&P ATRC unavailable / 14.46% |
| 2018-Q12/3 |
WinATRC / S&P 12.50% / -0.76% |
WinATRC / S&P 12.46% / 7.68% |
LoseATRC / S&P ATRC unavailable / 12.46% |
| 2017-Q41/3 |
LoseATRC / S&P -18.46% / 6.64% |
WinATRC / S&P 12.64% / 7.03% |
LoseATRC / S&P ATRC unavailable / 13.82% |
| 2017-Q31/3 |
LoseATRC / S&P -7.75% / 4.48% |
WinATRC / S&P 13.35% / 5.68% |
LoseATRC / S&P ATRC unavailable / 17.57% |
| 2017-Q22/3 |
WinATRC / S&P 26.63% / 3.09% |
WinATRC / S&P 16.17% / 4.83% |
LoseATRC / S&P ATRC unavailable / 17.74% |
| 2017-Q11/3 |
LoseATRC / S&P -2.15% / 6.07% |
WinATRC / S&P 18.14% / 3.67% |
LoseATRC / S&P ATRC unavailable / 13.32% |
| 2016-Q42/3 |
WinATRC / S&P 23.70% / 3.82% |
WinATRC / S&P 19.54% / 2.09% |
LoseATRC / S&P ATRC unavailable / 7.05% |
| 2016-Q32/3 |
WinATRC / S&P 11.96% / 3.85% |
WinATRC / S&P 21.50% / 0.20% |
LoseATRC / S&P ATRC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ATRC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 33.20% | 20.78% |
| Annualized return | 33.20% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ATRC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -34.22% | 83.14% |
| Annualized return | -8.04% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ATRC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 217.87% | 319.30% |
| Annualized return | 12.26% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |